LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
-5.41%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
AUM
$868M
AUM Growth
+$868M
Cap. Flow
+$19M
Cap. Flow %
2.19%
Top 10 Hldgs %
50.33%
Holding
70
New
16
Increased
12
Reduced
15
Closed
15

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NUVB.WS icon
51
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$10.7K ﹤0.01%
66,666
ALNY icon
52
Alnylam Pharmaceuticals
ALNY
$58.6B
0
CGEM icon
53
Cullinan Oncology
CGEM
$456M
-700,000
Closed -$11.9M
CGON icon
54
CG Oncology
CGON
$2.19B
-300,000
Closed -$13.2M
CLDX icon
55
Celldex Therapeutics
CLDX
$1.57B
-650,000
Closed -$27.3M
CYTK icon
56
Cytokinetics
CYTK
$5.98B
-100,000
Closed -$7.01M
FULC icon
57
Fulcrum Therapeutics
FULC
$353M
0
GERN icon
58
Geron
GERN
$893M
-9,000,000
Closed -$29.7M
IMCR icon
59
Immunocore
IMCR
$1.78B
-900,000
Closed -$58.5M
IMTX icon
60
Immatics
IMTX
$662M
-1,000,000
Closed -$10.5M
IMUX icon
61
Immunic
IMUX
$79.4M
-421,184
Closed -$556K
KURA icon
62
Kura Oncology
KURA
$732M
-300,000
Closed -$6.4M
LPTX icon
63
Leap Therapeutics
LPTX
$12M
-39,500
Closed -$105K
LRMR icon
64
Larimar Therapeutics
LRMR
$337M
0
PRAX icon
65
Praxis Precision Medicines
PRAX
$980M
-150,000
Closed -$9.15M
SNDX icon
66
Syndax Pharmaceuticals
SNDX
$1.39B
-350,000
Closed -$8.33M
TRML icon
67
Tourmaline Bio
TRML
$645M
-99,208
Closed -$2.27M
VRDN icon
68
Viridian Therapeutics
VRDN
$1.59B
-700,000
Closed -$12.3M
XBI icon
69
SPDR S&P Biotech ETF
XBI
$5.29B
0
KYTX icon
70
Kyverna Therapeutics
KYTX
$161M
-500,000
Closed -$12.4M